MARROSU, MARIA GIOVANNA
 Distribuzione geografica
Continente #
EU - Europa 414.946
NA - Nord America 21.802
AS - Asia 7.121
SA - Sud America 938
AF - Africa 112
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 20
Totale 444.960
Nazione #
IT - Italia 409.565
US - Stati Uniti d'America 21.570
CN - Cina 3.208
SG - Singapore 2.995
UA - Ucraina 1.830
SE - Svezia 1.123
BR - Brasile 814
DE - Germania 645
GB - Regno Unito 626
FI - Finlandia 537
VN - Vietnam 268
FR - Francia 212
KR - Corea 177
CA - Canada 159
IN - India 103
NL - Olanda 80
HK - Hong Kong 65
RU - Federazione Russa 57
AR - Argentina 47
MX - Messico 46
BE - Belgio 42
ES - Italia 40
PL - Polonia 40
AT - Austria 38
BD - Bangladesh 35
ZA - Sudafrica 35
JP - Giappone 30
EC - Ecuador 27
MA - Marocco 27
TR - Turchia 26
IQ - Iraq 24
EU - Europa 21
PK - Pakistan 21
CZ - Repubblica Ceca 18
IL - Israele 18
IR - Iran 18
SA - Arabia Saudita 18
AU - Australia 17
CO - Colombia 16
UZ - Uzbekistan 16
AZ - Azerbaigian 13
LT - Lituania 13
ID - Indonesia 12
VE - Venezuela 11
DZ - Algeria 10
RO - Romania 10
CH - Svizzera 9
MU - Mauritius 9
CL - Cile 8
IE - Irlanda 8
AE - Emirati Arabi Uniti 7
AL - Albania 7
EG - Egitto 7
UY - Uruguay 7
CU - Cuba 6
DK - Danimarca 6
JO - Giordania 6
KG - Kirghizistan 6
MY - Malesia 6
NP - Nepal 6
OM - Oman 6
KE - Kenya 5
LB - Libano 5
PH - Filippine 5
PT - Portogallo 5
TH - Thailandia 5
TN - Tunisia 5
BG - Bulgaria 4
CR - Costa Rica 4
ET - Etiopia 4
JM - Giamaica 4
NG - Nigeria 4
NO - Norvegia 4
PS - Palestinian Territory 4
EE - Estonia 3
GT - Guatemala 3
HR - Croazia 3
HU - Ungheria 3
LU - Lussemburgo 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
PY - Paraguay 3
BO - Bolivia 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GR - Grecia 2
KH - Cambogia 2
KZ - Kazakistan 2
MD - Moldavia 2
MK - Macedonia 2
RS - Serbia 2
SK - Slovacchia (Repubblica Slovacca) 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
AF - Afghanistan, Repubblica islamica di 1
AO - Angola 1
BA - Bosnia-Erzegovina 1
Totale 444.943
Città #
Cagliari 402.269
Uta 5.995
Fairfield 2.579
Woodbridge 2.181
Ashburn 1.807
Chandler 1.562
Houston 1.445
Singapore 1.320
Wilmington 1.149
Ann Arbor 1.055
Seattle 1.017
Boardman 927
Jacksonville 901
Dallas 876
Cambridge 861
Nyköping 722
Beijing 621
Dearborn 400
Nanjing 358
Los Angeles 257
Boston 247
Hefei 242
New York 239
Helsinki 234
Santa Clara 230
Shanghai 208
Buffalo 179
Seoul 169
Milan 167
The Dalles 137
San Diego 133
Shenyang 130
Munich 125
Nanchang 106
Toronto 99
Guangzhou 93
Hebei 91
Redwood City 90
Jiaxing 87
Ho Chi Minh City 86
Norwalk 83
Verona 82
Changsha 80
London 80
São Paulo 75
Washington 70
Sassari 64
Tianjin 63
Hong Kong 60
Redondo Beach 60
Chicago 52
Atlanta 50
Hanoi 47
Mountain View 46
Jinan 44
Zhengzhou 44
Hangzhou 41
Dong Ket 40
Ningbo 37
Rome 36
Phoenix 35
Warsaw 35
Columbus 34
Auburn Hills 32
Brooklyn 32
Brussels 32
Orange 30
Stockholm 30
Taizhou 29
Council Bluffs 28
Kunming 27
Pune 27
San Jose 27
Tokyo 26
Johannesburg 24
Rio de Janeiro 24
Nuremberg 22
San Francisco 22
Montreal 20
Porto Alegre 19
Belo Horizonte 18
Falls Church 18
Vienna 18
Amsterdam 17
Düsseldorf 17
Chennai 16
Curitiba 16
Millbury 16
Wuhan 16
Brasília 15
Frankfurt am Main 15
Orem 15
Denver 14
Florence 14
Mexico City 14
Tashkent 14
Casablanca 13
Edinburgh 13
Elk Grove Village 13
Haiphong 13
Totale 433.408
Nome #
Natalizumab in aggressive multiple sclerosis after haematopoietic stem cell transplantation 6.134
(1)H-NMR analysis provides a metabolomic profile of patients with multiple sclerosis 5.914
Vitamin D responsive elements within the HLA-DRB1 promoter region in Sardinian multiple sclerosis associated alleles 5.185
Erratum to: Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population (Neurological Sciences, (2017), 38, 6, (1019-1025), 10.1007/s10072-017-2905-x 4.900
Evaluation of Stroop color word test as cognitive task to investigate cognitive motor interference during walking in Multiple Sclerosis 4.537
EFFECTS OF SIX MONTHS TRAINING ON PHYSICAL CAPACITY AND METABOREFLEX ACTIVITY IN PATIENTS WITH MULTIPLE SCLEROSIS. 4.461
Quantitative assessment of alterations induced by spasticity on gait of individuals with multiple sclerosis using 3D gait analysis 4.442
Is Geo-Environmental Exposure a Risk Factor for Multiple Sclerosis? A Population-Based Cross-Sectional Study in South-Western Sardinia 4.356
Role of interferon-beta in Mycobacterium avium subspecies paratuberculosis antibody response in Sardinian MS patients 4.277
C9ORF72 intermediate repeat expansion in patients affected by atypical Parkinsonian syndromes or parkinson’s disease complicated by psychosis or dementia in a Sardinian population 4.249
The burden of multiple sclerosis variants in continental Italians and Sardinians 4.182
Quantitative assessment of the effects of 6 months of adapted physical activity on gait in people with multiple sclerosis: a randomized controlled trial 4.180
Overexpression of the cytokine BAFF and autoimmunity risk 4.057
Intrathecal oligoclonal bands synthesis in multiple sclerosis: is it always a prognostic factor? 3.989
Assessment of geochemical factors in multiple sclerosis distribution in the South-Western Sardinia 3.966
Mycobacterium avium subsp. Paratuberculosis and multiple sclerosis in Sardinian patients: Epidemiology and clinical features 3.881
HLA-DRB1-DQB1 haplotypes confer susceptibility and resistance to multiple sclerosis in Sardinia 3.868
What do multiple sclerosis patients and their caregivers perceive as unmet needs? 3.833
Clinical Assessment of Gait in Individuals with Multiple Sclerosis Using Wearable Inertial Sensors: Comparison with Patient-Based Measure 3.810
Exploring cognitive motor interference in multiple sclerosis by the visual Stroop test 3.800
Effectiveness and Limitations of Unsupervised Home-Based Balance Rehabilitation with Nintendo Wii in People with Multiple Sclerosis 3.769
Interaction between HLA-DRB1-DQB1 haplotypes in Sardinian multiple sclerosis population 3.762
Fatigue, as measured using the Modified Fatigue Impact Scale, is a predictor of processing speed improvement induced by exercise in patients with multiple sclerosis: data from a randomized controlled trial 3.695
The Required Coefficient of Friction for evaluating gait alterations in people with Multiple Sclerosis during gait 3.652
Performance in daily activities, cognitive impairment and perception in multiple sclerosis patients and their caregivers 3.629
Walking improvements with nabiximols in patients with multiple sclerosis 3.623
Localized pigmentation disorder after subcutaneous pegylated interferon beta-1a injection 3.589
Quantifying gait impairment in individuals affected by Charcot-Marie-Tooth disease: the usefulness of gait profile score and gait variable score 3.558
Multiple sclerosis and HLA genotypes: A possible influence on brain atrophy 3.548
Factors influencing MS outcome in Sardinia: a clinical and genetic study 3.541
Dynamical insights into the differential characteristics of Mycobacterium avium subsp. paratuberculosis peptide binding to HLA-DRB1 proteins associated with multiple sclerosis 3.389
The impact of modifiable risk factors on lesion burden in patients with early multiple sclerosis 3.381
Impact of brain atrophy on walking in multiple sclerosis patients with low disability: a dual task study. 3.375
Impact of the media on future hope in multiple sclerosis 3.353
Long-term follow-up more than 10 years after HSCT: a monocentric experience 3.273
Association between brain atrophy and cognitive motor interference in multiple sclerosis 3.265
Are static and functional balance abilities related in individuals with Multiple Sclerosis? 3.254
Cardiac involvement in patients with lamin A/C gene mutations: a cohort observation 3.217
A comparison of the brief international cognitive assessment for multiple sclerosis and the brief repeatable battery in multiple sclerosis patients 3.181
Oral agents in multiple sclerosis 3.180
Influence of treatments in multiple sclerosis disability: a cohort study 3.148
A genetic study of the FMR1 gene in a Sardinian multiple sclerosis population 3.072
Metabolomic analysis identifies altered metabolic pathways in Multiple Sclerosis 3.057
An unusual infection in MS patient treated with dimethyl fumarate: A case report of omphalitis 3.032
Population based study of 12 autoimmune diseases in Sardinia, Italy: prevalence and comorbidity 3.023
Brain volume in early MS patients with and without IgG oligoclonal bands in CSF 3.001
Refining the connection between gait and cognition: training the body to improve the brain 2.943
Charcot–Marie–Tooth disease: genetic subtypes in the Sardinian population 2.941
Relationship between gait initiation and disability in individuals affected by multiple sclerosis 2.940
Variants within the immunoregulatory CBLB gene are associated with multiple sclerosis 2.938
Effect of 6 months of adapted physical activity on gait patterns in individuals with multiple sclerosis: a three-dimensional quantitative analysis 2.903
Multiple sclerosis risk: interaction between human leukocyte antigen and the environment in Sardinian population 2.850
Cognition in multiple sclerosis: Between cognitive reserve and brain volume 2.833
Effect of spasticity on kinematics of gait and muscular activation in people with multiple sclerosis 2.779
Structural and dynamical insights on HLA-DR2 complexes that confer susceptibility to multiple sclerosis in Sardinia: a molecular dynamics simulation study 2.695
Postural adaptation during a Nintendo Wii balance training 2.639
C9ORF72 repeat expansion and bipolar disorder–is there a link? No mutation detected in a Sardinian cohort of patients with bipolar disorder 2.639
Perception of risk and shared decision making process in multiple sclerosis 2.618
Smoothness of gait detects early alterations of walking in persons with multiple sclerosis without disability 2.611
Cardiac and muscle imaging findings in a family with X-linked Emery-Dreifuss muscular dystrophy 2.584
Variation within the CLEC16A gene shows consistent disease association with both multiple sclerosis and type 1 diabetes in Sardinia 2.536
Pregnancy outcome in multiple sclerosis women treated with mitoxantrone 2.529
Serum BAFF levels, Methypredsinolone therapy, Epstein-Barr Virus and Mycobacterium avium subsp. paratuberculosis infection in Multiple Sclerosis patients 2.509
Neuroactive steroid levels in plasma and cerebrospinal fluid of male multiple sclerosis patients 2.484
Dopamine dysregulation syndrome in Parkinson's disease patients on levodopa-carbidopa intestinal gel 2.479
Vitamin D serum levels and balance are not related in Multiple Sclerosis 2.408
Genetic loci linked to type 1 diabetes and multiple sclerosis families in Sardinia 2.404
Antigenic epitopes of MAP2694 homologous to T-cell receptor gamma-chain are highly recognized in multiple sclerosis Sardinian patient 2.379
Attitude towards physical activity in patients with multiple sclerosis: a cohort study 2.308
Evaluation of high doses of ascorbic acid efficacy in Charcot Marie Tooth type 1A 2.305
Balance patterns in people with multiple sclerosis using Nintendo Wii 2.295
The cohort of the multiple sclerosis center of Cagliari 2.284
Muscle elastography: a new imaging technique for multiple sclerosis spasticity measurement 2.272
Evolution of the phenotype in a family with an LMNA gene mutation presenting with isolated cardiac involvement 2.263
Muscle MRI findings in patients with an apparently exclusive cardiac phenotype due to a novel LMNA gene mutation 2.260
Induction and escalation therapies in multiple sclerosis 2.253
Study of autonomic cardiovascular dysfunction in Parkinson’s disease patients with LRRK2 mutations using Heart Rate Variability 2.252
Dilated cardiomyopathy with conduction defects in a patient with partial merosin deficiency due to mutations in the laminin-α2-chain gene: a chance association or a novel phenotype? 2.243
Presence of oligoclonal IgG bands in Sardinians with multiple sclerosis is influenced by carriage of different HLA DRB1-DQB1 haplotypes 2.232
Cognitive screening in patients with amyotrophic lateral sclerosis in early stages 2.223
Thyroid antibodies in the CSF of Sardinian multiple sclerosis patients 2.195
Aberrant splicing in the LMNA gene caused by a novel mutation on the polypyrimidine tract of intron 5 2.172
Muscle imaging analogies in a cohort of patients with different clinical phenotypes caused by LMNA gene mutations 2.079
Multiple sclerosis and fertilization in vitro with embryo transfer (FIVET): a case report 2.057
Genetic analysis for five LRRK2 mutations in a Sardinian parkinsonian population: Importance of G2019S and R1441C mutations in sporadic Parkinson’s disease patients 2.027
Variation of the myelin oligodendrocyte glycoprotein gene is not primarily associated with multiple sclerosis in the Sardinian population 2.023
Medulloblastoma induces unusual headache with clinical picture of basilar-type migraine complicated by ischaemic infarcts 2.019
Interaction of loci within the HLA region influences multiple sclerosis course in the Sardinian population 2.016
Partial lipodystrophy associated with muscular dystrophy of unknown genetic origin 2.008
Novel Characterization of Gait Impairments in People with Multiple Sclerosis by Means of the Gait Profile Score 2.005
Reversible Pisa syndrome in patients with Parkinson's disease on dopaminergic therapy 1.976
The co-inheritance of type 1 diabetes and multiple sclerosis in Sardinia cannot be explained by genotype variation in the HLA region alone 1.954
Validation of the DYMUS questionnaire for the assessment of dysphagia in multiple sclerosis 1.910
Pregnancy decision-making in women with multiple sclerosis treated with natalizumab: II: Maternal risks 1.903
Lack of evidence for a role of the myelin basic protein gene in multiple sclerosis susceptibility in Sardinian patients 1.896
Genetic and clinical characteristics of skeletal and cardiac muscle in patients with lamin A/C gene mutations 1.889
The Italian multiple sclerosis register 1.885
Heat shock protein 27 R127W mutation: evidence of a continuum between axonal Charcot-Marie-Tooth and distal hereditary motor neuropathy 1.880
Bipolar affective disorder preceding frontotemporal dementia in a patient with C9ORF72 mutation: is there a genetic link between these two disorders? 1.860
The risk of bipolar disorders in multiple sclerosis 1.858
Totale 301.031
Categoria #
all - tutte 559.653
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 559.653


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202149.971 0 0 0 0 0 13.273 9.905 7.691 3.352 6.296 5.866 3.588
2021/202219.556 2.607 1.488 880 1.633 1.641 1.192 889 965 1.828 1.971 2.385 2.077
2022/202325.276 2.399 3.587 3.377 2.012 1.978 2.629 1.021 2.241 1.494 1.561 1.817 1.160
2023/202425.498 1.717 1.379 914 1.899 2.630 3.971 2.736 2.234 1.266 2.153 2.465 2.134
2024/202567.173 22.181 21.114 7.671 4.106 2.654 2.740 3.703 381 685 651 596 691
2025/20267.099 1.042 703 1.783 1.371 1.188 1.012 0 0 0 0 0 0
Totale 445.706